Cyclic GMP-Dependent Protein Kinases
"Cyclic GMP-Dependent Protein Kinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of cyclic GMP-dependent enzymes that catalyze the phosphorylation of SERINE or THREONINE residues of proteins.
| Descriptor ID |
D017869
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.150.150 D12.644.360.200.150 D12.776.476.200.150
|
| Concept/Terms |
Cyclic GMP-Dependent Protein Kinases- Cyclic GMP-Dependent Protein Kinases
- Cyclic GMP Dependent Protein Kinases
- Guanosine Cyclic 3',5'-Phosphate-Dependent Protein Kinase
- Guanosine Cyclic 3',5' Phosphate Dependent Protein Kinase
- G-Kinases
- G Kinases
- cGMP-Dependent Protein Kinases
- Kinases, cGMP-Dependent Protein
- Protein Kinases, cGMP-Dependent
- cGMP Dependent Protein Kinases
- Protein Kinase G
- G-Kinase
- G Kinase
- Cyclic GMP-Dependent Protein Kinase
- Cyclic GMP Dependent Protein Kinase
- Guanosine Cyclic Monophosphate-Dependent Protein Kinases
- Guanosine Cyclic Monophosphate Dependent Protein Kinases
|
Below are MeSH descriptors whose meaning is more general than "Cyclic GMP-Dependent Protein Kinases".
Below are MeSH descriptors whose meaning is more specific than "Cyclic GMP-Dependent Protein Kinases".
This graph shows the total number of publications written about "Cyclic GMP-Dependent Protein Kinases" by people in this website by year, and whether "Cyclic GMP-Dependent Protein Kinases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclic GMP-Dependent Protein Kinases" by people in Profiles.
-
Yule DI, Betzenhauser MJ, Joseph SK. Linking structure to function: Recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesis. Cell Calcium. 2010 Jun; 47(6):469-79.
-
Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1. J Physiol. 2009 Jul 15; 587(Pt 14):3587-603.
-
Neppl RL, Lubomirov LT, Momotani K, Pfitzer G, Eto M, Somlyo AV. Thromboxane A2-induced bi-directional regulation of cerebral arterial tone. J Biol Chem. 2009 Mar 06; 284(10):6348-60.
-
Pitari GM, Baksh RI, Harris DM, Li P, Kazerounian S, Waldman SA. Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins. Cancer Res. 2005 Dec 01; 65(23):11129-35.
-
Teixeira CC, Ischiropoulos H, Leboy PS, Adams SL, Shapiro IM. Nitric oxide-nitric oxide synthase regulates key maturational events during chondrocyte terminal differentiation. Bone. 2005 Jul; 37(1):37-45.
-
Wagner LE, Li WH, Joseph SK, Yule DI. Functional consequences of phosphomimetic mutations at key cAMP-dependent protein kinase phosphorylation sites in the type 1 inositol 1,4,5-trisphosphate receptor. J Biol Chem. 2004 Oct 29; 279(44):46242-52.
-
Li F, De Godoy M, Rattan S. Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle. J Pharmacol Exp Ther. 2004 Mar; 308(3):1111-20.
-
Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, Ma XL, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue TL. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation. 2003 Dec 02; 108(22):2805-11.
-
Gainey LF, Greenberg MJ. Nitric oxide mediates seasonal muscle potentiation in clam gills. J Exp Biol. 2003 Oct; 206(Pt 19):3507-20.
-
Piazza GA, Thompson WJ, Pamukcu R, Alila HW, Whitehead CM, Liu L, Fetter JR, Gresh WE, Klein-Szanto AJ, Farnell DR, Eto I, Grubbs CJ. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res. 2001 May 15; 61(10):3961-8.